Study of DE-105 Ophthalmic Solution in Patients With Persistent Corneal Epithelial Defect

NCT00988494 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Persistent Corneal Epithelial Defect

Interventions

DRUG: DE-105 ophthalmic solution
DRUG: DE-105 ophthalmic solution
DRUG: Placebo ophthalmic solution

Sponsor

Santen Pharmaceutical Co., Ltd.